Research Suggests Adding Neurology-Forward Clinical Model to Standard of Care Can Improve BPSD Outcomes
Crown Point, IN, Jan. 27, 2025 - Research published by GuideStar Eldercare suggests that adding a neurology-forward clinical model to the existing standard of care for residents with Alzheimer’s disease and related dementias could significantly improve Behavioral and Psychological Symptoms of Dementia (BPSD) outcomes. The research article, “The Rate of Use of Acetylcholinesterase Inhibitors and/or the NMDA Antagonist Memantine in Long-Term Care Residents With Dementia at Risk for BPSD,” appears in Annals of Long-Term Care, Jan. 16, 2025.
Most residents of long-term care facilities have neurocognitive impairment, note the authors, and most meet CMS criteria for axis I diagnosis during their residency. The newly published Practical Research article builds on existing knowledge that the mechanisms of action of acetylcholinesterase Inhibitors and memantine are complementary—and that using these medications together can improve clinical outcomes in residents living with dementia.
The team studied the neuropharmacology of 121 long-term care residents in four buildings that were new to GuideStar Eldercare services. GuideStar researchers found that only 22% of residents were currently receiving any BPSD-specific neurologic medications, and only 5% were optimally treated with the combination of the two classes of medication. These findings point to a significant opportunity to improve dementia care and clinical outcomes in long-term care facilities by implementing a neurology-forward care model.
“Alzheimer’s disease and vascular, mixed, Parkinson, and Lewy body-related dementias comprise approximately 90% of cases of ADRD among [long-term care] residents, and all are amenable to this primary approach to BPSD intervention,” said the authors.
Authors Steven Posar, MD, Anita Reid, APN, FNP-BC, GNP-BC, and Daniel Heiser, PsyD of GuideStar Eldercare have been pioneers in defining and advocating a neurology-forward approach to dementia care for nursing home residents. Dr. Posar and GuideStar clinicians actively present and publish on the neurology-forward care model and effective protocols for antipsychotic reduction.
About GuideStar Eldercare
GuideStar Eldercare is the national leader in neurobehavioral services, providing expert neuropsychiatric and dementia care to long-term care facilities. Our neurologically based model ensures proper diagnosis and treatment, which improves care outcomes for patients with dementia, neurocognitive impairments, and/or psychiatric conditions. GuideStar Eldercare can be reached by phone at phone at 888-837-5440. More info: guidestareldercare.com.